Kinex Pharma makes clinical leadership appointments
This article was originally published in Scrip
Executive Summary
Buffalo, New York-based Kinex Pharmaceuticals has appointed two key executives to its clinical leadership team. Dr Douglas Kramer, a former medical officer for the US FDA, joins the company as vice-president of clinical and regulatory affairs. Meanwhile Jane Devance, who previously worked at Schering-Plough (Merck), has been appointed director of clinical operations. They will both report directly to Kinex's chief medical officer Dr Rudolf Kwan.